Warning: Illegal string offset 'enable' in /home/redhothe/public_html/wp-content/plugins/conditional-widgets/logic.php on line 171
RED HOT Contributors


Merck cancer immunotherapy drug gets expansion to biomarker-based labeling

CREDIT: This post was originally published on this site

The FDA approved Keytruda as a single agent for patients with first-line metastatic or unresectable colorectal cancer that carries the biomarker MSI-H or dMMR. The drug was the first to win a biomarker-based, tumor-agnostic label, in 2017.



We Support OUR Contributors

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast